CVC-625

Cefuroxime Shows

• Clinical success rate & gt:98%
• Equally effective against Gm+ve and Gm-ve Bacteria
• Stopping bacterial over growth from First Dose
• Minimum chances of cross resistance.

Clavulanate Potassium

• Overcomes Beta lactamase induced resistance
• Helps Kill MRSA, VRSA and Atypical strains
• Augments the action of Cefuroxime against resistant Gm-ve stains including Pseudomonus, e. colic and Klebsiella

Urinary Tract Infections

Bone and Joint Infections

Gonorrhea

Skin and Soft Tissue Infection

Community Acquired Pneumonia